Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA
1.1.6 - Reconciliation + Stage 2 Connectathon
Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA
1.1.6 - Reconciliation + Stage 2 Connectathon
Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.6 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions
Generated Narrative: SubstanceDefinition ffa30c0b-8031-436a-87f1-635b3bbe5989
identifier: hydroxyApatite
classification: Degradation Product
structure
technique: formed from dicalcium phosphate degradation
representation
type: Structure
representation: XZFUZCHOJLQYHV-UHFFFAOYSA-M
representation
type: Structure
representation: [OH-].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
| Code |
| 91D9GV0Z28 |
| Name | Type | Preferred |
| TRIBASIC CALCIUM PHOSPHATE | GSRS Preferred Term | true |
IG © 2021+ HL7 International / Biomedical Research and Regulation. Package hl7.fhir.us.pq-cmc-fda#1.1.6 based on FHIR 5.0.0. Generated 2024-09-22
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change